Ratio Therapeutics and PharmaLogic Expand Manufacturing Pact for Targeted Radiotherapy Candidate Ac225RTX2358 SGMO Q1 2026 Earnings EPS Misses Estimates as No Revenue Reported Stock Rises 5 Mortgage Rate Outlook Tied to 10Year Treasury Yield Movements